期刊档案 · Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Acta Materia Medica
ISSN 2737-7946 · Compuscript Ltd · Ireland
Acta Materia Medica 钻石开放获取（无 APC），免版面费，投稿社区反馈审稿约 13 周，2025 年发文 43 篇，Scopus 收录。
研究范围
研究范围与定位
Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management. Coverage includes: •Pathophysiology of important diseases and disease vectors • Novel therapeutic strategies • Novel methodologies facilitating the search for therapies • High-throughput screening, combinatorial chemistry, parallel synthesis and library design • 3D Structures and functions of therapeutic targets • Structural biological studies of relevant ligands and targets • Discovery, design and synthesis of biologically active agents, including natural products, therapeutic macromolecules • Drug delivery • ADME/Toxicology • Advances in key compound classes and therapeutic areas • Omics in pharmaceutical sciences • Biological databases, web-based software for pharmaceutical sciences • Studies of biological activity or mode of action. • Structure-activity correlations of drugs • Development of new imaging and diagnostic tools • Computational studies the SAR of compounds, target informatics • Business strategy for pharmaceutical industry • Clinical research and trials, meta-analysis •Management, commercial and regulatory issues in pharmaceutical R&D. • Other aspects of pharmacy and pharmaceutical sciences. Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Biochemistry, Genetics and Molecular Biology-Molecular Medicine
主编 Hongxi Xu出版商官网
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Protein Degradation and InhibitorsBiochemistry, Genetics and Molecular Biology10.3%
- Nanoplatforms for cancer theranosticsEngineering8.9%
- Ubiquitin and proteasome pathwaysBiochemistry, Genetics and Molecular Biology8.2%
- Computational Drug Discovery MethodsComputer Science5.5%
- Histone Deacetylase Inhibitors ResearchBiochemistry, Genetics and Molecular Biology4.8%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics4.8%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.1%
- Ferroptosis and cancer prognosisMedicine4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 11.4LetPub ·
- SJR 2026-06
- 1.13LetPub ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 21OpenAlex ·
- i10-index
- 53OpenAlex ·
- 两年平均被引
- 3.49OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 162 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 12 | 12 | 0 |
| 2025 | 43 | 43 | 98 |
| 2024 | 33 | 33 | 209 |
| 2023 | 36 | 36 | 516 |
| 2022 | 38 | 38 | 813 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 13 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 13 周DOAJ ·
- 评审方式
- Anonymous peer reviewDOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY | |
| LetPub | 无文章处理费 | 无 | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型17 种，含篇幅限制
- case reportActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 1,200 词
- commentariesActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- commentaryActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 2,000 词
- editorialActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 2,500 词
- editorialsActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- letter to the editorActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 1,000 词
- mini-reviewsActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- original researchActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- protocolActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 4,000 词
- research articleActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 5,000 词
- research articlesActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- reviewActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- review articleActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- review articlesActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- short communicationActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…正文 ≤ 3,000 词
- short communicationsActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
- study protocolActa Materia Medica publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study p…未说明篇幅
官网政策摘录利益冲突、数据可用性、试验注册 / 报告规范
- 利益冲突 Competing Interests
Conflict of interests/competing interests can be defined as factors which could influence the judgment of an author, reviewer or editors, and may be personal, commercial, political, academic, or financial in nature. Put simply, they are interests which, if revealed later, would make a reasonable reader feel misled or deceived.
原文 ↗出版商官网 ·- 数据可用性
Data and Materials Sharing 模型摘要
Acta Materia Medica is committed to improving scholarly communications and as part of this commitment, authors may make materials, data and associated protocols available to readers.
原文 ↗出版商官网 ·- 试验注册 / 报告规范
Clinical Trials Registration 模型摘要
The journal adheres to ICMJE’s Clinical Trials Registration Statement. All clinical trials published in the journal must be registered in a public trial’s registry at or before the onset of participant enrolment.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Compuscript Ltd
- 出版国家或地区
- Ireland
- 出版语言
- English
- ISSN
- 2737-7946
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
常见问题
关于 Acta Materia Medica 的常见问题
Acta Materia Medica 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 13 周。社区反馈来自投稿者样本，不代表期刊承诺。
Acta Materia Medica 是开放获取期刊吗？版面费多少？
Acta Materia Medica 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。